Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

382 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M, Melichar B, Sedláková I, Steiner I. Tomsová M, et al. Among authors: melichar b. Gynecol Oncol. 2008 Feb;108(2):415-20. doi: 10.1016/j.ygyno.2007.10.016. Epub 2007 Nov 26. Gynecol Oncol. 2008. PMID: 18037158
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS. Melichar B, et al. Clin Exp Immunol. 2000 Jan;119(1):19-27. doi: 10.1046/j.1365-2249.2000.01105.x. Clin Exp Immunol. 2000. PMID: 10606960 Free PMC article.
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD. Freedman RS, et al. Among authors: melichar b. Clin Cancer Res. 2000 Jun;6(6):2268-78. Clin Cancer Res. 2000. PMID: 10873077 Clinical Trial.
Intestinal permeability in patients with chemotherapy-induced stomatitis.
Melichar B, Kohout P, Brátová M, Solichová D, Králícková P, Zadák Z. Melichar B, et al. J Cancer Res Clin Oncol. 2001 May;127(5):314-8. doi: 10.1007/s004320000209. J Cancer Res Clin Oncol. 2001. PMID: 11355146
The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy.
Melichar B, Tousková M, Dvorák J, Jandík P, Kopecký O. Melichar B, et al. Immunopharmacol Immunotoxicol. 2001 May;23(2):163-73. doi: 10.1081/iph-100103857. Immunopharmacol Immunotoxicol. 2001. PMID: 11417845
The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries.
Melichar B, Tousková M, Tosner J, Kopecký O. Melichar B, et al. Onkologie. 2001 Apr;24(2):156-60. doi: 10.1159/000050304. Onkologie. 2001. PMID: 11441296
CD4+ T-lymphocytopenia and systemic immune activation in patients with primary and secondary liver tumours.
Melichar B, Tousková M, Solichová D, Králicková P, Kopecký G. Melichar B, et al. Scand J Clin Lab Invest. 2001;61(5):363-70. doi: 10.1080/003655101316911404. Scand J Clin Lab Invest. 2001. PMID: 11569483
Immunology of the peritoneal cavity: relevance for host-tumor relation.
Melichar B, Freedman RS. Melichar B, et al. Int J Gynecol Cancer. 2002 Jan-Feb;12(1):3-17. doi: 10.1046/j.1525-1438.2002.01093.x. Int J Gynecol Cancer. 2002. PMID: 11860531 Review.
Regional chemotherapy in biliary tract cancers--a single institution experience.
Melichar B, Cerman J Jr, Dvorák J, Jandík P, Mergancová J, Melicharová K, Tousková M, Krajina A, Voboril Z. Melichar B, et al. Hepatogastroenterology. 2002 Jul-Aug;49(46):900-6. Hepatogastroenterology. 2002. PMID: 12143237
Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer.
Melichar B, Touskova M, Vesely P. Melichar B, et al. Hepatogastroenterology. 2002 Jul-Aug;49(46):967-70. Hepatogastroenterology. 2002. PMID: 12143255
382 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback